TABLE 3 in Descriptions of two new species of Aporcelinus Andrássy, 2009 (Nematoda: Dorylaimida: Aporcelaimidae) and a new record from Iran

TABLE 3. Main morphometrics of Aporcelinus taromensis sp. nov. from Iran. Measurements in µm except L in mm, and in the form: average ± sd (range). CharacterType populationSecond populationHolotypeParatypesVoucher specimens♀♀♀♂♂♀♀♂♂n5536L2.192.11 ± 0.6 (2.03–2.19)2.15 ± 0.1 (1.97–2.36)2.13 ± 0.1 (2.05–2.28)2.23 ± 0.1 (1.99–2.42)a26.126.4 ± 1.6 (24.1–28.5)30 ± 2.4 (26.3–32.3)29 ± 2.9 (25.8–31.6)33.7 ± 2.8 (28.4–35.7)b4.34.1 ± 0.1 (4.0–4.3)4.2 ± 0.1 (4.0–4.5)4.4 ± 0.1 (4.2–4.6)4.4 ± 0.1 (4.3–4.6)c37.836.8 ± 3.3 (32.8–40.8)38.6 ± 4.6 (32.7–44.7)37.4 ± 5.1 (31.6–41.2)36.7 ± 3.2 (32.1–40.5)c´1.61.6 ± 0.03 (1.6)1.5 ± 0.07 (1.4–1.6)1.7 ± 0.2 (1.5–2.0)1.6 ± 0.1 (1.4–1.8)V/T5050.7 ± 1.2 (49.5–52.4)58.6 ± 3.1 (55.1–63)52.8 ± 1.6 (51–54.3)57 ± 2.0 (53.6–58.9)Lip region diameter1918.3 ± 1.4 (17–20)19.1 ± 0.7 (18–20)17.7 ± 0.5 (17–18)17.8 ± 0.6 (17–18.5)Odontostyle length (dorsal)2121.9 ± 0.8 (21–23)21.8 ± 0.4 (21–22)21.8 ± 0.2 (21.5–22)21.3 ± 1.1 (20–22.5)Odontophore length3535 ± 1.4 (34–37)33.8 ± 0.8 (33–35)34.7 ± 1.1 (34–36)35.7 ± 2.6 (33–40)Neck length509514 ± 15 (507–523)507 ± 32.9 (455–532)482 ± 20.5 (460–500)503 ± 31.3 (466–548)Pharyngeal expansion length245236 ± 11.8 (220–246)233 ± 25.2 (200–267)228 ± 19.7 (211–250)224 ± 17.9 (210–260)Body diameter at neck base7371.3 ± 6.7 (65–80)67.4 ± 2.7 (65–72)67.3 ± 4.6 (62–70)60.5 ± 4.0 (55–65)mid-body8480.5 ± 7.3 (73–89)71.8 ± 2.7 (68–75)74 ± 7.9 (65–80)66.5 ± 4.4 (61–71)anus/cloaca3736 ± 2.7 (32–38)37.9 ± 4.2 (33–44)32.3 ± 3.0 (29–35)38 ± 1.6 (36–41)Vulva to anterior end10861072 ± 24.5 (1040–1096)-1127 ± 97.7 (1052–1238)-Prerectum length7486.3 ± 13.4 (74–104)136.2 ± 17.1 (110–155)75 ± 5.0 (70–80)126.5 ± 24.5 (84-152)Rectum/cloaca length4441.5 ± 1.7 (40–44)50.6 ± 7.2 (43–61)40.7 ± 1.1 (40–42)49.5 ± 6.8 (41–60)Tail length5857.8 ± 4.7 (51–62)56.4 ± 8 (48–66)57.7 ± 7.5 (50–65)61.1 ± 4.4 (55–68)Spicule length--82.8 ± 5.5 (73–86)-79.2 ± 3.8 (76–85)Ventromedian supplements--18 ± 2 (16–21)-16 ± 2 (16–17)